Daiwa downgraded Abbott (ABT) to Neutral from Outperform with a price target of $92, down from $113.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Abbott price target lowered to $143 from $144 at Barclays
- Abbott Reaches Preliminary Settlement in Derivative Governance Case
- Abbott says data at AACR demonstrate advancements in Cancerguard test
- Abbott Labs Stock (ABT) Hit with Slew of Downgrades After Earnings
- Abbott price target lowered to $130 from $135 at RBC Capital